Jan 26, 2026
Most ViewedWhich cancer types show the strongest preclinical response to ivermectin and why (mechanistic targets like PAK1, Akt/mTOR)?
Preclinical literature shows produces the most robust anticancer signals in (including triple‑negative), , , , (non‑small cell) and certain models, largely because it targets multiple survival and res...